首页 产品目录 分子砌块 按官能团 试剂 2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

514-36-3

英文名称

2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

别名

17-dihydroxy-20-dion(11-beta)-pregn-4-ene-21-(acetyloxy)-9-fluoro-11;20-dione,9-fluoro-11-beta,17,21-trihydroxy-pregn-4-ene-21-acetate;9-alpha-fluorohydrocortisone-21-acetate;9-alpha-fluorohydrocortisoneacetate;9-fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione21-acetate;9-fluoro-17-hydroxy-corticosteron21-acetate;FLUDROCORTISONEACETATE,MICRONIZED,USP;9α-Fluoro-11β,17α,21-trihydroxypregn-4-ene-3,20-dione 21-acetate

标准英文名

2-((8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate

分子式

C23H31FO6

分子量

422.49

精确分子量

422.21

SMILES

CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C

标准SMILES

CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C

用途

Fludrocortisone acetate is the only mineralocorticoid recommended by U.S. clinical guidelines for the treatment of salt-wasting congenital adrenal hyperplasia and Addison's disease. It is primarily used for its mineralocorticoid activity in primary adrenal insufficiency and can be combined with glucocorticoids for replacement therapy. It is also indicated for conditions such as hypoaldosteronism with low renin, and orthostatic hypotension caused by autonomic neuropathy.

InChIKey

SYWHXTATXSMDSB-GSLJADNHSA-N

安全信息

SureRoute逆合成路线

1.  514-36-3 逆合成路线 1

ACCZIU451
563-67-7
—
—
ACJEUX461
514-36-3
来源: SureRoute

2.  514-36-3 逆合成路线 2

—
—
ACJEUX461
514-36-3
来源: SureRoute

3.  514-36-3 逆合成路线 3

—
—
ACJEUX461
514-36-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手